Navigation Links
MedImmune to present RSV surveillance and cost-effectiveness data at American Academy of Pediatrics

SAN FRANCISCO, October 26, 2007 MedImmune, Inc. today announced it will present three abstracts at the American Academy of Pediatrics (AAP) 2007 National Conference & Exhibition, adding to the companys growing body of research into the prevention of respiratory syncytial virus (RSV), a leading cause of hospitalization among infants.

MedImmune is pleased to present data that provide key insights into how we can optimize the fight against RSV, said Jessie R. Groothuis, M.D., vice president, medical and scientific affairs, infectious disease. Cost-effectiveness data help insurers, governments, and families understand the benefits of RSV prophylaxis and the potential impact of not taking preventive measures. Surveillance data help us understand local variants in RSV outbreaks, which can inform and improve RSV prevention guidelines.

MedImmune abstracts to be presented at AAP include:

  • Cost-Effectiveness of Respiratory Syncytial Virus Prophylaxis with Palivizumab Among Preterm Infants After Valuing a Reduction in Persistent Wheezing (Poster #P14) Mark J. Polak, M.D., Saturday, October 27th, 2007 from 12:15 1:00 p.m.

    BACKGROUND: Recent trials have suggested that Synagis (palivizumab), a monoclonal antibody (MAb) that is the standard of care in RSV prevention, reduced the incidence of persistent wheezing in studied populations. Researchers conducted a cost-effectiveness analysis of prophylaxis with Synagis compared with no prophylaxis among preterm infants less than 32 weeks and between 32 and 35 weeks gestation, factoring in the quality of life associated with a reduction in persistent wheezing.

  • A Nationwide Hospital RSV Surveillance Program: Interim Assessment of the 2006-2007 RSV Season (Poster #P25) Marnie L. Boron, PharmD, Saturday, October 27th, 2007 from 12:15 1:00 p.m.

    BACKGROUND: Due to limited uniformity in RSV testing and local surveillance reporting, nationwide RSV prevention programs are not optimal. A nationwide surveillance program was initiated to track and report RSV activity at the local level in a timely manner. This abstract includes an interim report of the data collected to date.

  • Regional Respiratory Syncytial Virus Surveillance Data for Georgia and Implications for Prophylactic Administration of Palivizumab (Poster #P32) Mark Eggleston, PharmD, MBA, Saturday, October 27th, 2007 from 12:15 1:00 p.m.

    BACKGROUND: The Georgia Division of Public Health initiated an RSV surveillance program in mid-2000 to monitor RSV activity within four regions of the state. This study aimed to identify the onset, duration, and peak month of the RSV season in each of the four regions and evaluate whether national guidelines for RSV prophylaxis with Synagis are sufficient or whether recommendations should be based on local RSV virology data.


Contact: Tor Constantino
Edelman Public Relations

Related medicine news :

1. Surgeons Presented Guidelines For Postoperative Atrial Fibrillation
2. Researchers Present Ways To Reduce The Risk Of Dementia
3. Researchers Present Data Regarding The Efficiency Of Herbs
4. Critically Ill Patients More At Risk Of Infection If Glucose Is Present In Their Lung Secretions
5. Ovarian Cancer Presents ‘Target Symptoms’ Six Months Before Diagnosi
6. Drug Reactions First Present Themselves In The Mouth
7. Reminiscing Into The Past Makes You Dissatisfied With The Present
8. Living In The Past Indicates Dissatisfaction With Present
9. Movies Represent Coma In A Wrong Way
10. Onchocerciasis: Presentation And Treatment
11. Researchers Warn That Routine Physical Examination Could Miss Breech Presentation
Post Your Comments:
(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... ... offering factory direct sauna parts and accessories. , Sauna accessories help improve ... the bather’s style and personality. From basic styles for the purist looking for ...
(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... For the ... companies’ “ Two Organizations, One Beat ” campaign. The partnership between the two groups ... to aid in MAP International’s cause. , MAP International was founded in 1954 and ...
(Date:11/25/2015)... ... 2015 , ... On November 25, 2015, officials of Narconon Arrowhead , ... release of a new cutting edge recovery program that has been 50 years in ... and alcohol-addicted individuals with the purpose to free addicts from the symptoms and negative ...
(Date:11/25/2015)... ... November 25, 2015 , ... Smiles by Stevens is ... and moderate facial wrinkling. While many patients are aware of the benefits of Botox® ... Botox® delivers to those suffering with discomfort, soreness, and pain as a result of ...
(Date:11/25/2015)... ... ... In an ongoing Clinical Study conducted by an independent physician, Andrew Gostine, MD, ... the efficacy of its product and its disinfection protocol. This study is taking place ... through October 2015 at a 360-bed, acute-care, academic medical center located in Chicago, Illinois. ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... 26, 2015 ... "2016 Future Horizons and Growth Strategies ... Market: Supplier Shares, Country Segment Forecasts, Competitive ... offering. --> ) has ... Future Horizons and Growth Strategies in the ...
(Date:11/26/2015)... 26, 2015 ... of the  "2016 Future Horizons and ... Drug Monitoring (TDM) Market: Supplier Shares, ... Opportunities"  report to their offering.  ... the addition of the  "2016 Future ...
(Date:11/26/2015)... -- Research and Markets ( ) has ... Horizons and Growth Strategies in the Italian Therapeutic ... Forecasts, Competitive Intelligence, Emerging Opportunities" report to ... --> This new 247-page report provides ... monitoring market, including emerging tests, technologies, instrumentation, sales ...
Breaking Medicine Technology: